Lista de obras -

3-Year Follow-up of the NIMH MTA Study

artículo científico publicado en 2007

ADHD comorbidity findings from the MTA study: comparing comorbid subgroups

artículo científico publicado en 2001

Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate ⬇️

artículo científico publicado el 1 de febrero de 1979

Acute treatment response and short term outcome in schizophrenia: first results of the NIMH treatment strategies in schizophrenia study. Treatment Strategies in Schizophrenia Collaborative Study Group

scientific article published on 01 January 1989

Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA).

artículo científico publicado en 2000

Assessing medication effects in the MTA study using neuropsychological outcomes

article

Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD.

artículo científico publicado en 2012

Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study

artículo científico publicado en 2014

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment

artículo científico publicado en 2001

Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression

article

Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study

artículo científico publicado en 2014

Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program

artículo científico publicado en 2015

Consistency checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS).

artículo científico publicado en 2017

Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment Program

artículo científico publicado en 2016

Delinquent Behavior and Emerging Substance Use in the MTA at 36 Months: Prevalence, Course, and Treatment Effects

article

Demographic characteristics, treatment history, presenting psychopathology and early course in schizophrenia. Treatment Strategies in Schizophrenia Collaborative Study Group

artículo científico publicado en 1989

Depot fluphenazine in the prevention of relapse in schizophrenia: evaluation of a treatment regimen [proceedings]

artículo científico publicado el 1 de abril de 1979

Development and Prediction of Postpsychotic Depression in Neuroleptic-Treated Schizophrenics ⬇️

artículo científico publicado el 1 de febrero de 1982

Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study

scientific article published on 01 January 1980

Does multimodal treatment of ADHD decrease other diagnoses?

article

Duration of Untreated Psychosis in Community Treatment Settings in the United States

artículo científico publicado en 2015

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

artículo científico publicado en 2005

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment

artículo científico publicado en 2006

Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic

artículo científico publicado en 2006

Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD.

artículo científico publicado en 2003

Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution

artículo científico publicado en 2002

Ensuring data quality in a multicenter clinical trial: remote site data entry, central coordination and feedback

artículo científico publicado en 1989

Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers

artículo científico publicado en 2001

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

artículo científico publicado en 2004

How can registries contribute to the development and evaluation of CNS therapeutics?

artículo científico publicado en 2013

Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial

artículo científico publicado en 2001

Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium

artículo científico publicado en 2013

Maintenance treatment of schizophrenia: a review of dose reduction and family treatment strategies

artículo científico publicado en 1995

Medication treatment strategies in the MTA Study: relevance to clinicians and researchers

artículo científico publicado en 1996

Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder

artículo científico publicado en 2011

Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA.

artículo científico publicado en 2001

Multimodal treatment of ADHD in the MTA: an alternative outcome analysis

artículo científico publicado en 2001

National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices

artículo científico publicado en 1997

Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures

artículo científico publicado en 2004

Observed classroom behavior of children with ADHD: relationship to gender and comorbidity

artículo científico publicado en 2002

Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study

article

Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder

artículo científico publicado en 2005

Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?

artículo científico publicado en 2017

Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study

artículo científico publicado en 2014

Prevention of relapse in schizophrenia. An evaluation of fluphenazine decanoate

artículo científico publicado en 1980

Relapse and Rehospitalization During Maintenance Treatment of Schizophrenia

artículo científico publicado en 1997

Reliability of the services for children and adolescents-parent interview

artículo científico publicado en 2004

Response to commentary on the multimodal treatment study of ADHD (MTA): mining the meaning of the MTA.

artículo científico publicado en 2002

Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses

artículo científico publicado en 2007

Socioeconomic status as a moderator of ADHD treatment outcomes

artículo científico publicado en 2002

Stabilization and depot neuroleptic dosages

artículo científico publicado en 1993

Symptom profiles in children with ADHD: effects of comorbidity and gender

artículo científico publicado en 2001

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes

artículo científico publicado en 2007

The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up

artículo científico publicado en 2009

Transition from acute to maintenance treatment: prediction of stabilization

scientific article published on 01 May 1996

Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder

artículo científico publicado en 2006

Which treatment for whom for ADHD? Moderators of treatment response in the MTA.

artículo científico publicado en 2003

Lista de obras de

3-Year Follow-up of the NIMH MTA Study

ADHD comorbidity findings from the MTA study: comparing comorbid subgroups

Acute extrapyramidal reactions with fluphenazine hydrochloride and fluphenazine decanoate ⬇️

Acute treatment response and short term outcome in schizophrenia: first results of the NIMH treatment strategies in schizophrenia study. Treatment Strategies in Schizophrenia Collaborative Study Group

Anxiety as a predictor and outcome variable in the multimodal treatment study of children with ADHD (MTA).

Assessing medication effects in the MTA study using neuropsychological outcomes

Blood pressure and heart rate over 10 years in the multimodal treatment study of children with ADHD.

Cardiometabolic risk in patients with first-episode schizophrenia spectrum disorders: baseline results from the RAISE-ETP study

Clinical relevance of the primary findings of the MTA: success rates based on severity of ADHD and ODD symptoms at the end of treatment

Comparison of Early Intervention Services vs Treatment as Usual for Early-Phase Psychosis: A Systematic Review, Meta-analysis, and Meta-regression

Comparison of SGA oral medications and a long-acting injectable SGA: the PROACTIVE study

Comprehensive Versus Usual Community Care for First-Episode Psychosis: 2-Year Outcomes From the NIMH RAISE Early Treatment Program

Consistency checks to improve measurement with the Positive and Negative Syndrome Scale (PANSS).

Cost-Effectiveness of Comprehensive, Integrated Care for First Episode Psychosis in the NIMH RAISE Early Treatment Program

Delinquent Behavior and Emerging Substance Use in the MTA at 36 Months: Prevalence, Course, and Treatment Effects

Demographic characteristics, treatment history, presenting psychopathology and early course in schizophrenia. Treatment Strategies in Schizophrenia Collaborative Study Group

Depot fluphenazine in the prevention of relapse in schizophrenia: evaluation of a treatment regimen [proceedings]

Development and Prediction of Postpsychotic Depression in Neuroleptic-Treated Schizophrenics ⬇️

Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study

Does multimodal treatment of ADHD decrease other diagnoses?

Duration of Untreated Psychosis in Community Treatment Settings in the United States

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

Effectiveness of clozapine versus olanzapine, quetiapine, and risperidone in patients with chronic schizophrenia who did not respond to prior atypical antipsychotic treatment

Effectiveness of olanzapine, quetiapine, risperidone, and ziprasidone in patients with chronic schizophrenia following discontinuation of a previous atypical antipsychotic

Effects of ethnicity on treatment attendance, stimulant response/dose, and 14-month outcome in ADHD.

Emergency/Adjunct services and attrition prevention for randomized clinical trials in children: the MTA manual-based solution

Ensuring data quality in a multicenter clinical trial: remote site data entry, central coordination and feedback

Findings from the NIMH Multimodal Treatment Study of ADHD (MTA): implications and applications for primary care providers

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial

How can registries contribute to the development and evaluation of CNS therapeutics?

Impairment and deportment responses to different methylphenidate doses in children with ADHD: the MTA titration trial

Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium

Maintenance treatment of schizophrenia: a review of dose reduction and family treatment strategies

Medication treatment strategies in the MTA Study: relevance to clinicians and researchers

Methods to limit attrition in longitudinal comparative effectiveness trials: lessons from the Lithium Treatment - Moderate dose Use Study (LiTMUS) for bipolar disorder

Methylphenidate dosage for children with ADHD over time under controlled conditions: lessons from the MTA.

Multimodal treatment of ADHD in the MTA: an alternative outcome analysis

National Institute of Mental Health Collaborative Multimodal Treatment Study of Children with ADHD (the MTA). Design challenges and choices

Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures

Observed classroom behavior of children with ADHD: relationship to gender and comorbidity

Parenting and family stress treatment outcomes in attention deficit hyperactivity disorder (ADHD): an empirical analysis in the MTA study

Peer-assessed outcomes in the multimodal treatment study of children with attention deficit hyperactivity disorder

Predicting relapse in schizophrenia: Is BDNF a plausible biological marker?

Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study

Prevention of relapse in schizophrenia. An evaluation of fluphenazine decanoate

Relapse and Rehospitalization During Maintenance Treatment of Schizophrenia

Reliability of the services for children and adolescents-parent interview

Response to commentary on the multimodal treatment study of ADHD (MTA): mining the meaning of the MTA.

Secondary evaluations of MTA 36-month outcomes: propensity score and growth mixture model analyses

Socioeconomic status as a moderator of ADHD treatment outcomes

Stabilization and depot neuroleptic dosages

Symptom profiles in children with ADHD: effects of comorbidity and gender

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes

The Treatment for Adolescents With Depression Study (TADS): outcomes over 1 year of naturalistic follow-up

Transition from acute to maintenance treatment: prediction of stabilization

Treatment-related changes in objectively measured parenting behaviors in the multimodal treatment study of children with attention-deficit/hyperactivity disorder

Which treatment for whom for ADHD? Moderators of treatment response in the MTA.